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We describe a farmer who presented with a clinical picture of a transverse thoracic myelitis. MRI showed inﬂammatory lesions
in brain and thoracic spinal cord. Toxocariasis was suspected because of eosinophilia in blood and cerebrospinal ﬂuid, and this
diagnosis was conﬁrmed immunologically. He was successfully treated with antihelminthics in combination with corticosteroids.
Neurotoxocariasis is rare and diagnosis can be diﬃcult because of the diﬀerent and atypical clinical manifestations. It should be
considered in every case of central neurological syndrome associated with eosinophilia.
1.Introduction
Toxocariasis is a parasitic zoonosis caused by larvae of
Toxocara canis or Toxocara cati. These nematodes normally
live in the small intestine of domestic dogs and cats, their
deﬁnitive hosts. Most human infections are thought to be
subclinical or self-limited, and clinical infections usually
aﬀect young children and manifest most commonly with
pulmonary or hepatic disease. Clinical involvement of the
central nervous system is rare and probably occurs as a result
of hematogenous dissemination [1, 2].
2.CaseReport
A previously healthy 45-year-old farmer presented at the
emergency department with a tingling sensation and weak-
ness in the lower limbs. The symptoms started 1 week earlier
and were gradually progressive. He also noticed diﬃculty
with micturition since the past few days. He did not have
upper limb complaints nor back pain, and he denied any
recent back trauma, infection, or vaccination. He had not
been in foreign countries. On clinical examination, there was
a symmetrical paresis of the lower limbs (global grade 4/5
on MRC scale, though the proximal muscle groups being
slightly weaker), with a sensory loss of all modalities below
thoracic dermatome level 10, brisk deep tendon reﬂexes in
the lower limbs, and bilateral Babinski signs. Over the next
2 days, his case deteriorated into paraplegia with anaesthesia
in the lower limbs and total loss of control of bladder and
bowel. Spinal MRI showed an intramedullary T2-weighted
hyperintensity extending from thoracic level 4 to 10 with-
out contrast enhancement (Figure 1). Brain MRI showed
multiple T2-weighted hyperintense lesions, the largest lying
posterior to the left lateral ventricle (Figures 2 and 3).
The supratentorial lesions showed contrast enhancement
(Figure 4), the one in the pons did not. Examination of
cerebrospinal ﬂuid (CSF) revealed 25 leukocytes/µLw i t h
87% lymphocytes, 9% eosinophils, 33mg/dL of protein, and
62mg/dL of glucose; IgG index was normal (0.62); there
were no oligoclonal IgG bands. The relative amount of
peripheral blood eosinophils was increased to 21% with the
total white blood cell count being normal (8.300/mm3). C-
reactive protein and routine biochemical blood tests were all
normal. Ophthalmologic examination was normal, as were
thoracic and abdominal CT scans. Treatment was started
with intravenous methylprednisolone (1g q24h for 5 days).
ThepresenceofeosinophilsinthebloodandCSFsuggesteda
parasitic infection, and therefore oral mebendazole (200mg
q12h) was added. Antibody titer against Toxocara canis using
ELISA (for excretory-secretory antigen) was 1:500 positive
in blood and 1:32 positive in cerebrospinal ﬂuid. A broad
screeningforotherneurotropicinfections(includingTaenia)2 Case Reports in Medicine
Figure 1: Sagittal T2-weighted spinal MRI shows an intramedullar
hyperintenselesionextendingfromT4toT10(betweenthearrows).
was negative. The patient did not own domestic dogs, but
multiple cats were free-living on his farm. He regularly
soiled his hands while feeding hay to his cattle, and he did
never wash his hands before meals. A diagnosis of Toxocara
encephalomyelitis was made, and he was further treated with
oral albendazole 400mg q12h (11mg/kg body weight) for
16 days and oral methylprednisolone starting with 64mg
q24handslowlytaperingoﬀthedosage.Heslowlyrecovered.
About 2 months after the onset of symptoms, he could
walk independently but still with slight disability. Imaging
of spinal cord and brain at that time showed complete
resolution of lesions (Figures 5 and 6).
3. Discussion
Humantoxocariasisisazoonosiscausedbyinfectivelarvaeof
Toxocara canis or (less often) Toxocara cati. These nematodes
live as adult worms in the intestinal tract of dogs and cats,
respectively. Humans are usually infected by ingestion of
embryonatedeggsinsoil,mostoftenoncontaminatedhands
[1, 2]. The migration of larvae to various tissues causes
pathologic and immunologic responses with granulomatous
inﬂammation and eosinophilia [2–4]. Visceral involvement
of the disease is called visceral larva migrans (VLM) [2].
Most Toxocara infections are probably subclinical or benign
and self-limiting. The typical patients are children between
the ages of 2 and 7 years with a history of geophagia and
exposure to puppies or kittens athome or in public parks [1–
3].Someexpertshavedisputedtheroleofdogsastransmitter
because up to half of patients do not own a pet and cannot
recall any close animal contact [4]. The clinical signs of VLM
are usually associated with hepatic and pulmonary larval
migration and include abdominal pain, decreased appetite,
restlessness, fever, coughing, wheezing, asthma, and hep-
atomegaly. Infection is usually characterized by marked and
chronic eosinophilia, leukocytosis, and hypergammaglobu-
linemia [1–3]. In ocular larva migrans (OLM), involvement
Figure 2: Axial T2-weighted brain MRI shows a large left-sided
hyperintense occipital lesion.
Figure 3: Sagittal FLAIR brain MRI shows a lesion cranial to the
corpus callosum and the large occipital lesion.
is restricted to the eye and the optic nerve. OLM typically
presents as unilateral vision impairment that is sometimes
accompanied by strabismus. The most serious consequence
of infection is invasion of the retina, leading to granuloma
formation. Blindness is a common complication [2].
Neurological manifestations of toxocariasis are rare.
In the English language medical literature from 1950 to
2007, we found only 31 cases of neurological toxocari-
asis in humans [1, 5, 6]. Possible clinical syndromes
are encephalopathy, meningoencephalitis, transverse myeli-
tis, psychiatric disturbances, focal or generalized seizures,
epilepsy, and death [3]. For a brief overview of the main
clinical and paraclinical data of 21 patients from 1956 until
2002, we refer to the article by Moreira-Silva et al. [7]. In
l i t e r a t u r e ,w eh a v ee n c o u n t e r e do n l y5p r e v i o u sc a s e so f
Toxocara myelitis (with MRI and positive serology in blood
and CSF), all of them made a good recovery [5, 6]. Recently,Case Reports in Medicine 3
Figure 4: Axial postcontrast T1-weighted brain MRI shows a
contrast-enhanced left-sided lesion in the periventricular white
matter.
Figure 5: Sagittal T2-weighted spinal MRI 2 months later shows
complete resolution of the lesion.
a 2-year-old child with Toxocara encephalomyelitis has been
reported, pointing out the possible resemblance to acute
disseminated encephalomyelitis [6].
The enzyme-linked immunosorbent assay (ELISA), that
uses antigens secreted by the second-stage larvae, is the
best indirect test for diagnosing infection. The ELISA has
a reasonably high sensitivity of approximately 78% at a
titer greater than 1:32 [2]. A disadvantage of this test
is that anti-Toxocara antibodies measured by ELISA were
found to persist for up to 2.8 years in infected adults
so that the presence of these antibodies alone does not
distinguish between current and past infections [1]. In
northern industrialized countries, the seroprevalence of this
infection is 5% in urban adults and up to 40% in children
andruralfarmers.IntheWestIndiesandBali,seroprevalence
Figure 6: Axial T2-weighted brain MRI 2 months later shows
complete resolution of the occipital lesion.
rates approach 80% [1, 4]. Therefore, one should also take
into account blood eosinophilia, which is considered to be
a reliable indicator of active helminthiasis, serum IgE, and
nonspeciﬁc tests such as erythrocyte sedimentation rate and
C-reactive protein in case of VLM. Neurological syndromes
with Toxocara infection of the central nervous system are
generally nonspeciﬁc, and peripheral eosinophilia is often
lacking. MRI can detect granulomas located cortically and
subcortically, and these may appear as hyperintense foci on
T2-weighted and proton density images. When associated
with eosinophilia in the CSF, such images suggest a Toxocara
infection. The presence of Toxocara larvae in cerebrospinal
ﬂuid, in brain tissue or in the meninges, and/or a positive
anti-Toxocara antibody titre in CSF, can conﬁrm the diagno-
sis [1]. In cases of cerebral and spinal parenchymal lesions in
combination with eosinophilia in blood and CSF, one should
also consider neurocysticercosis, especially in endemic areas.
Neurocysticercosis typically presents with epileptic seizures
and one or multiple cystic brain lesions. Although very
rare, cases of extramedullary and intramedullary spinal
neurocysticercosis have been described [8, 9].
Acute VLM should be treated. Diﬀerent treatment regi-
mens exist. Diethylcarbamazine (DEC), if available, is often
considered the most eﬀective treatment [1, 4]. It is given in a
dosage of 3 to 4mg/kg body weight in 3 divided doses daily
for 21 days. DEC should not be given together with corti-
costeriods because of being antagonism of corticosteriods,
which partially inhibit DEC’s mechanism of action. There-
fore, DEC and corticosteriods must be given sequentially.
The drug has been associated with a high rate (28%) of neu-
rological side eﬀects (especially dizziness and headache) and
(in 10%) a Mazzotti-like reaction (itching, urticaria, and/or
oedema).Mebendazole(MBZ)isavailableinmanycountries
and would appear to be a good alternative to DEC, for
example, if the occurrence of major DEC-related side eﬀects
is feared. Dosage is 20 to 25mg/kg body weight (in a single
dose) daily for 3 to 4 weeks. The drug is practically insoluble
in water and should be taken with a fatty meal [1, 4].4 Case Reports in Medicine
Albendazole (ABZ) is given at 10 to 15mg/kg body weight
in 2 divided doses daily for 5 to 15 days and is considered
by several authors as the treatment of choice [2, 3]. Thiaben-
dazole (TBZ) is not recommended because of a high rate of
side eﬀects (including cholestasis and hepatitis) [1]. Corti-
costeroids are sometimes added to antihelminthics to reduce
the acute inﬂammatory and immunologic manifestations
[1–3]. In neurotoxocariasis in particular, corticosteroids are
thought to be important because the central nervous system
lesions are more likely to represent inﬂammatory reactions
rather than abscess formation [1, 5].
4. Conclusion
We present this case because of the unusual combination
of spinal cord and cerebral lesions in toxocariasis. To our
knowledge, our patient represents the ﬁrst adult described
in English literature with concomitant involvement of brain
and spinal cord (documented with MRI). Neurotoxocariasis
can result in varying and atypical neurological manifes-
tations, including one that simulates acute disseminated
encephalomyelitis. One should consider neurotoxocariasis
in every central neurological syndrome associated with
eosinophilia. Treatment consists of the combination of anti-
helminthics and corticosteroids. A detailed history taking is
important,especiallywithregardtotravelling.Toxocaracanis
occursworldwide.Ifthepatienthasrecentlytravelledabroad,
diﬀerential diagnosis of eosinophilic meningitis/myelitis is
more extensive and includes Taenia solium, Gnathostoma
spinigerum, Angiostrongylus cantonensis, and Baylisascaris
procyonis [8–10].
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